Angiographic and clinical outcomes from 396 aneurysms treated with the pipeline flex embolization device with shield technology

Our results demonstrate high rates of complete long-term occlusion among patients treated with pipeline embolization device with shield technology. We also observed low rates of mortality and morbidity consistent with fewer thromboembolic complications with pipeline embolization devices with shield technology.